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ABSTRACT
Capillary electrophoresis (CE) procedure was developed for determining glucosamine content in nutraceuticals. Glucosamine was
labeled with o-phthalaldehyde (OPA) by mixing with the OPA reagent (4.5 mM OPA, 4.5 mM 2-mercaptoethanol dissolved in 20 mM
borate buffer, pH 9.3). The fluorescent OPA-glucosamine adduct was separated and detected at A340 within 3 min. The pre-capillary
labeling reaction can be performed by sequentially injecting OPA/sample/OPA segments into the separation capillary; the in-capillary
labeling technique simplified the sample pretreatment and improved its reproducibility. The linear dynamic range of the in-capillary
labeling CE method was 0.1~30 mM. No sample pretreatment procedure was required for tablets containing mainly starch or other
sugar as the vehicles.
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INTRODUCTION
Glucosamine is an important building block for
cartilage, tendons and other connective tissues. This
natural chemical has additional functions in inhibiting
enzymes that destroy cartilage(1). Oral administration of
glucosamine has been reported to show clinical effects in
re-growing cartilage and slowing down joint deterioration
without significant adverse effects (2). Therefore, the
simple aminosugar has become the most popular ingredient
in nutraceuticals for the treatment of osteoarthritis.
Simple and quick analytical methods for glucosamine
are required along with the growing market demand, but
the chemical species can hardly be analyzed optically or
electrochemically without derivatization (3,4). Reducing
end quantification methods such as MBTH (5) are not
suitable for most nutraceutical preparations since those
methods usually contain sugars as the vehicles. Methods
based on labeling the amino groups are considered for
determining amino sugars(6,7).
o-Phthaladehyde (OPA) is a popular f luorescent
labeling agent for amino group. The labeling reaction
occurs rapidly in room temperature and is frequently
applied as an on-line post-column derivatizing technique
for H PLC analysis of ami no acids and protei ns (8) .
Unfortunately, the reagent itself is unstable and reaction
comes with unidentified side reactions. Pre-column
labeling strategies are therefore practically difficult and
intensive column clean-up procedures are need after the
separation.
Capillary electrophoresis (CE)(9-12), a new analytical
* Author for correspondence. Tel: +886-2-33665330;
Fax: +886-2-23627620; E-mail: rlcchen@ccms.ntu.edu.tw

trend, is a rapid and ready-to-r un technique that is
especially suitable for routine and multi-sample analytical
tasks. Easy colum n clean-up f ur ther improves the
analytical speed and sample throughput.
In the present approach, pre-column OPA labeling
technique was adapted for determining glucosamine
by a rapid capillary zone electrophoresis procedure.
To improve the reproducibility and ease the automatic
sampling process, OPA reagent and the sample solution
were sequentially injected into the capillar y. The
labeling reaction occurred within the capillary, and the
fluorescent adduct was separated / detected in less than
3 min. Glucosamine content in the aqueous solutions
of nutraceutical tablets were determined (A 340 ) with
commercialized CE machine without sample pretreatment.

MATERIALS AND METHODS
I. Chemicals
o-Phthaladehyde (OPA), glucosamine hydrochloride
(M. Wt = 215.63), and 2-mercaptoethanol were purchased
from Wako Co. Sodium tertraborate (borax) was from
Nacalai Tesque Co. Glycine was from Sigma Co. Other
chemicals were of analytical grade and used without
purif ication. Commercial glucosamine tablets were
purchased from local drug stores.
Deionized water (< 1 μScm-1) was used for preparing
buffers, reagents and sample solutions.
II. pH Buffer, OPA Reagent and Sample Solutions
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possible to improve the reproducibility by performing the
reaction on-line within the separation capillary.
II. In-capillary Labeling of Glucosamine and Separation of
its OPA-derivatives
I n Fig u re 1, OPA-lab el i ng wa s p e r for me d by
sequentially injecting OPA reagent, sample solution and
then OPA reagent into the capillary. The separation was
not satisfactory when the reaction mixture was separated
immediately after the mixing process (the lower trace of
Figure 1). The separation was significantly improved by

A thermo-controlled (25°C) capillary electrophoresis
(CE) system (G1600A, Agilent) was used to obtain the
CEgrams. Before the experiments, an uncoated fusedsilica capillaries (length = 34 cm; effective length = 28.5
cm; O.D. = 375 μm; I.D. = 75 μm) were thoroughly rinsed
with 1 N NaOH (950 mbar × 40 min) and then deionized
water (950 mbar × 20 min).
The separation capillar y was rinsed (950 mbar
× 3 m i n) w it h t he r u n n i ng bu f fe r (20 m M bor at e
buffer, pH 9.3) im mediately before injection. The
electrophoretic separation process was monitored with
a built-in photodiode ar ray (PDA) detector. Af ter
the electrophoresis, the capillary was cleaned up by
sequentially rinsing with 1N NaOH (950 mbar × 3 min.)
and deionized water (950 mbar × 3 min). The above
procedures were controlled with ChemstationTM , the
software by Agilent.

1

Mixing time = 0 sec

20 mAu
2

0

1

2

3

4

5

Time (min)

Figure 1. Effects of mixing time on electropherogram. Capillary
were injected sequentially with OPA reagent (30 mbar × 5 sec),
glucosamine solution (10 mM; 30 mbar × 3 sec) and OPA reagent
(30 mbar × 5 sec), and then separated (10 kV) with the running
buffer of 20 mM borate, pH 9.3. A 340 was monitored. The
glucosamine (Peak 1) solution contained 5 mM glycine (Peak 2).
Other conditions are detailed in the experimental section.

introducing a brief time interval (i.e. 6 sec, as shown by
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A l t h o u g h O PA- a m i n e a d d u c t s w e r e u s u a l l y
measured fluorometrically, the sensitivity of photometric
measurement (A 340 ) is acceptable for measuring the
ingredient in pharmaceutical preparation. Acceptable
electropherograms (similar to those in Figure 1) can
be easily obtained by injecting (30 mbar × 3 sec) and
separating (10 kV in 20 mM borate, pH 9.3) a reaction
mixture containing 100 μL of 10 mM glucosamine,
100 μL of 5 mM glycine and 500 μL of OPA reagent.
However, the reproducibility of quantification was poor.
As directly monitoring A 340 of the OPA labeling
reaction in a quartz cuvette, the reaction readily reached
its ma xi mu m absorba nce i n approxi mately 2 m i n.
The rapid reaction kinetics is suitable for analytical
applications, but the decay in A 340 after about 5 min
implies unidentified problematic side reactions. It may be
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RESULTS AND DISCUSSION
I. Electrophoresis of the Reaction Mixture of OPA Reagent
and Glucosamine
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III. Instrumentation
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Borate buffer was prepared by dissolving sodium
tertraborate (borax) in deionized water as a 0.1 M stock
solution. The unadjusted pH was 9.3. The stock buffer
was stored at ambient temperature and diluted to suitable
extent for later uses.
O PA r e a g e n t w a s p r e p a r e d b y d i s s o l v i n g
o-phthalaldehyde solution (30 mg in 1 mL of ethanol) and
15 μL of 2-mercaptoethanol in 50 mL of 50 mM borate
buffer (pH 9.3). The OPA reagent (4.5 mM) was prepared
immediately before experiment.
Sample solutions were prepared by dissolving tablets
of nutraceutical with 100 mL of deionized water. The
solutions were filtered through a 0.22 μm membrane filter,
Carrigtwohill Co.

1.0

400

0.5

0.0

0
0

12

24

36

48

60

Mixing time (sec)

Figure 2. Effects of mixing time on the theoretical plate numbers
and resolutions of electropherograms. The experimental conditions
are shown in Figure 1. Open circles: theoretical plate numbers;
solid circles: resolutions.
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the upper trace of Figure 1) before imposing separation
voltage. However, further elongation of mixing time
dispersed the sample plug and reduced both the theoretical
plate number and the resolution (Figure 2). Twelve
seconds was the proper time interval for the present
experimental conditions and instrumentation.
The separation conditions were further optimized as in
Figure 3. With the increase of buffer concentration (Figure
3 A), the increasing ionic strength shielded the surface
charges of capillary wall, which resulted in lowering the
zeta potential and the velocity of electroosmotic flow. The
migration time was therefore reduced in low concentration
buffers. By considering the separation speed and buffer
capacity, 20 mM borate buffer was selected.
The separation voltage was selected to be 10 kV for
shorter migration time (Figure 3 B), sufficient theoretical

Migration time (min)

10

plate numbers (> 2000) and fewer joule-heating problem.
Migration time was not significantly affected by the pH of
running buffer (Figure 3 C). The unadjusted pH of borax
solution (pH 9.3) was used throughout the study.
Linearity of the calibration curve of the optimized
method (10 kV, 20 mM borate, pH 9.3, mixing time = 12
sec) was up to 30 mM (r2 = 0.9615) with detection limit
at 0.1 mM (S/N > 10). The CVs (n = 4) of peak area were
less than 7%.
III. Determination of Glucosamine in Nutraceuticals
Three types of glucosamine tablets were measured for
active ingredients, among which some tablets may contain
other chemicals with primary amino groups such as amino
acids and proteins (peak 3 of the upper trace in Figure
4). Judging from the spectra (Figure 5) obtained by the
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Figure 4. Electropherograms of a sample solution (upper trace) and
glucosamine standard solution (lower trace). The mixing time was
12 sec; other conditions are as in Figure 1. Peaks 1, 2 and 3 are
the signals of OPA-glucosamine, OPA-glycine and an unidentified
chemical, respectively. The standard solution contained 20 mM
glucosamine and 10 mM glycine.
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Figure 3. Effects of electrophoretic conditions on migration time
of OPA-labeled glucosamine. (A) 5 kV, pH 9.3, (B) 20 mM borate
buffer, pH 9.3, (C) 20 mM borate buffer, 10 kV. The mixing time
was 12 sec; other conditions are as in Figure 1.
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Figure 5. Comparison of the absorption spectra. Spectra of peak
1 (OPA-glucosamine) in Figure 4 were obtained with the built-in
PDA detector of the CE machine. Solid line: glucosamine standard;
dashed line: sample solution of a nutraceutical.
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built-in PDA detector, the purities of OPA-glucosamine
adducts (peak 1 in Figure 4) were nearly unity. Rapid
and efficient separation was performed and confirmed by
the purity check and the following data comparison. The
glucosamine contents in tree tablets were determined (n
= 4) to be 670 ± 31 mg, 447 ± 14 mg and 404 ± 29 mg,
somewhat lower than the labeled contents (750 mg, 500
mg and 450 mg, respectively).
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